CLINICAL_TRIALS
trial_result
· 2012-12-06
Clinical Trial Update: Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women [Phase 3]
Summary
A Phase 3 clinical trial evaluating Karinat for anti-atherosclerotic activity in postmenopausal women has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute for Atherosclerosis Research, Russia | Conditions: Atherosclerosis | Phase 3 | Status: COMPLETED